Report overview
Capsule-based inhalers belong to the category of dry powder inhalers and work according to a simple two-step procedure. Capsules are punctured or opened by pressing the device buttons. Then, after inspiration, powder is absorbed into the lung pathway.
This report aims to provide a comprehensive presentation of the global market for Capsule-based Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Capsule-based Inhalers. This report contains market size and forecasts of Capsule-based Inhalers in global, including the following market information:
Global Capsule-based Inhalers Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Capsule-based Inhalers Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Capsule-based Inhalers companies in 2022 (%)
The global Capsule-based Inhalers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Gelatin Capsules Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Capsule-based Inhalers include Hovione, Iconovo AB, Inbrija, Utibron Neohaler (Novartis AG) and Zibo Laixu Medical Equipment, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Capsule-based Inhalers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Capsule-based Inhalers Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Capsule-based Inhalers Market Segment Percentages, by Type, 2022 (%)
Gelatin Capsules
Hypromellose Capsules
Global Capsule-based Inhalers Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Capsule-based Inhalers Market Segment Percentages, by Application, 2022 (%)
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
Global Capsule-based Inhalers Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Capsule-based Inhalers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Capsule-based Inhalers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Capsule-based Inhalers revenues share in global market, 2022 (%)
Key companies Capsule-based Inhalers sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Capsule-based Inhalers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment
Outline of Major Chapters:
Chapter 1: Introduces the definition of Capsule-based Inhalers, market overview.
Chapter 2: Global Capsule-based Inhalers market size in revenue and volume.
Chapter 3: Detailed analysis of Capsule-based Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Capsule-based Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Capsule-based Inhalers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
